Matches in Wikidata for { <http://www.wikidata.org/entity/Q91563273> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91563273 description "article scientifique publié en 2020" @default.
- Q91563273 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91563273 description "scientific article published on 21 March 2020" @default.
- Q91563273 description "wetenschappelijk artikel" @default.
- Q91563273 description "наукова стаття, опублікована 21 березня 2020" @default.
- Q91563273 name "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 name "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 type Item @default.
- Q91563273 label "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 label "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 prefLabel "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 prefLabel "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 P1433 Q91563273-A02D566D-F925-42E9-9F22-272C17142DFA @default.
- Q91563273 P1476 Q91563273-400007D6-59B1-42DE-B95E-4527B53325C3 @default.
- Q91563273 P2093 Q91563273-004D85AB-0365-41BB-A1CE-1F276EFB143A @default.
- Q91563273 P2093 Q91563273-1DFF57BB-B880-4713-9DF2-6641EB7C5B27 @default.
- Q91563273 P2093 Q91563273-57E421A6-540F-4DB7-BA5A-313708DC4CDD @default.
- Q91563273 P2093 Q91563273-6AEC8E44-971A-4AD2-97C6-6118E1405825 @default.
- Q91563273 P2093 Q91563273-99A750CE-8B26-4E03-BB14-8F1530C6975A @default.
- Q91563273 P2093 Q91563273-A799B9EC-D3D9-42D2-8D82-03389DB36026 @default.
- Q91563273 P2093 Q91563273-BBBEAB17-4CC2-4778-AE67-A89F119FBA2D @default.
- Q91563273 P2093 Q91563273-BCC55703-9F08-467C-AA51-48ECFCC82B49 @default.
- Q91563273 P2093 Q91563273-E3134A27-AE55-40F6-8A7F-C1D394C3E244 @default.
- Q91563273 P2093 Q91563273-EE76A92E-55B7-43F0-9266-E8B2EB1C0A82 @default.
- Q91563273 P304 Q91563273-4A96294D-F618-4133-BB51-073FDBC9E52F @default.
- Q91563273 P31 Q91563273-A9E6DE96-4AB0-4644-ACA8-D5DBB476F663 @default.
- Q91563273 P356 Q91563273-CC1E784B-BB0C-4F86-8B47-5E6B1FD06681 @default.
- Q91563273 P478 Q91563273-ECCD3690-7973-4CDC-87ED-7A81EBF6A893 @default.
- Q91563273 P577 Q91563273-DCDD72F2-D6D9-4E9D-A542-8F10C223C378 @default.
- Q91563273 P698 Q91563273-90139B83-DCF1-4E01-A02B-374C962E586E @default.
- Q91563273 P921 Q91563273-33A0654E-0B9C-4CB6-B481-3E7FFB5C88C4 @default.
- Q91563273 P921 Q91563273-A9337D7A-9E8F-44C4-B242-833F270E5EF2 @default.
- Q91563273 P356 J.ATHEROSCLEROSIS.2020.03.015 @default.
- Q91563273 P698 32247073 @default.
- Q91563273 P1433 Q4813570 @default.
- Q91563273 P1476 "Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes" @default.
- Q91563273 P2093 "Bo Li" @default.
- Q91563273 P2093 "Feng Tian" @default.
- Q91563273 P2093 "Jin-Wen Tian" @default.
- Q91563273 P2093 "Jing-Wei Li" @default.
- Q91563273 P2093 "Mei Zhu" @default.
- Q91563273 P2093 "Wei-Ming Shi" @default.
- Q91563273 P2093 "Yan-Rong Luo" @default.
- Q91563273 P2093 "Ying-Qian Zhang" @default.
- Q91563273 P2093 "Yu Ding" @default.
- Q91563273 P2093 "Yun-Dai Chen" @default.
- Q91563273 P304 "10-18" @default.
- Q91563273 P31 Q13442814 @default.
- Q91563273 P356 "10.1016/J.ATHEROSCLEROSIS.2020.03.015" @default.
- Q91563273 P478 "300" @default.
- Q91563273 P577 "2020-03-21T00:00:00Z" @default.
- Q91563273 P698 "32247073" @default.
- Q91563273 P921 Q3025883 @default.
- Q91563273 P921 Q844935 @default.